Production (Stage)
CareRx Corporation
CRRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.72M | -3.26M | -4.37M | -5.18M | -2.77M |
| Total Depreciation and Amortization | 13.64M | 13.90M | 14.09M | 14.28M | 14.71M |
| Total Amortization of Deferred Charges | 112.90K | 112.90K | 137.50K | 137.50K | 137.50K |
| Total Other Non-Cash Items | 9.99M | 10.43M | 11.35M | 12.24M | 7.98M |
| Change in Net Operating Assets | 4.98M | 6.58M | 6.99M | 3.88M | 3.36M |
| Cash from Operations | 26.01M | 27.76M | 28.20M | 25.35M | 23.42M |
| Capital Expenditure | -4.70M | -4.05M | -3.39M | -2.72M | -3.19M |
| Sale of Property, Plant, and Equipment | 126.40K | 143.50K | 139.90K | 129.80K | 32.70K |
| Cash Acquisitions | -- | -- | -44.10K | -44.10K | -2.22M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.46M | -1.84M | -1.86M | -2.35M | -3.25M |
| Cash from Investing | -6.03M | -5.75M | -5.15M | -4.99M | -8.63M |
| Total Debt Issued | 2.30M | 1.80M | 60.30M | 60.30M | 60.30M |
| Total Debt Repaid | -22.67M | -23.38M | -112.42M | -108.29M | -102.15M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -801.00K | -801.00K | -555.00K | -280.00K | -56.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.71M | -5.64M | -6.58M | -8.06M | -7.14M |
| Cash from Financing | -20.21M | -20.47M | -43.51M | -41.44M | -36.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.00K | 1.54M | -20.47M | -21.09M | -21.38M |